Christopher McDaniels
Optometrist · Tulsa, OKNPI 1861705659
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 33.2% of the total. Reporting peaked in 2019 at $1,952 and has fallen 85.4% since, to $286 in 2025. Among optometrist clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $67.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- AbbVie$525
- Sun Pharmaceutical Industries Inc.$337
- Bausch & Lomb Americas Inc.$260
- Shire North American Group Inc$161
- plus $525 from 7 others
What the payments were for
- Consulting fees$1,49028%
- Travel & lodging$1,60831%
- Food & beverage$2,15041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 8 | $1,743 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $1,699 |
| AbbVie(2 entities) | 12 | $525 |
| Sun Pharmaceutical Industries Inc. | 9 | $337 |
| Bausch & Lomb Americas Inc. | 4 | $260 |
| Shire North American Group Inc | 6 | $161 |
| Oyster Point Pharma, Inc. | 8 | $142 |
| Alcon | 6 | $130 |
| Coopervision Inc. | 1 | $108 |
| Tarsus Pharmaceuticals, Inc. | 5 | $87 |
| Dompe US, Inc. | 1 | $23 |
| Novartis | 2 | $23 |
| ABB Con-cise Optical Group LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,490
- BIOTRUE$1,304
- ULTRA$1,304
- XEN GLAUCOMA TREATMENT SYSTEM$267
- CEQUA$239
- XIIDRA$234
- MIEBO$219
- Clariti Contact Lens$108
- DURYSTA$106
How this compares
$5,249 in reported general payments places this provider in the 90th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 57 | $46,254 |
| MieboPerfluorohexyloctane/Pf | 54 | $41,134 |
| CequaCyclosporine | 13 | $9,687 |
| Prednisolone Acetate | 125 | $3,510 |
| Dexamethasone Sodium Phosphate | 11 | $304 |
| Doxycycline Hyclate | 13 | $235 |
| Latanoprost | 17 | $91 |
| Cephalexin | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $525 | $46,25457 claims |
| Bausch & Lomb Americas Inc.Miebo | $260 | $41,13454 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $337 | $9,68713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 714 optometrist providers in Oklahoma.
Other optometrist in Tulsa
- Lindsey BullTulsa$218K
- Wesley DerosierTulsa$48K
- Brian WilliamsTulsa$9K
- Lynsey BigheartTulsa$9K
- Shannon MorgansTulsa$8K
- Blane SnodgrassTulsa$7K
- Brett BeasleyTulsa$6K
- Travis PartinTulsa$6K
- Terry LawsonTulsa$4K
- Selina McGeeEdmond$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.